Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by ARK Invest. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ARK Invest or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Redefining Medicine: Nobel Laureate David Baker On AI In Drug Discovery

50:04
 
Share
 

Manage episode 450129047 series 1532639
Content provided by ARK Invest. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ARK Invest or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this episode of FYI, ARK Chief Investment Strategist Dr. Charles Roberts and ARK Analyst Nemo Despot, PhD speak with David Baker, Nobel Prize-winning scientist and pioneer in protein engineering. Baker shares insights into his revolutionary work on Rosetta and the evolution of AI-driven protein design tools. With advances in technologies like RoseTTAFold and generative AI, he discusses how the field is moving towards designing proteins that can neutralize pathogens, catalyze chemical reactions, and potentially combat neurodegenerative diseases. Charlie and Nemo also examine the implications for healthcare, aging, and drug discovery as Baker envisions a future where synthetic biology and AI enable groundbreaking therapeutic options.

Key Points From This Episode:

  • Introduction of David Baker and his achievements in protein design and engineering.
  • RoseTTAFold’s evolution and its role in advancing protein structure prediction.
  • How protein design could impact healthcare and the development of new therapies.
  • The use of generative AI and diffusion models in protein design for medical applications.
  • Challenges of modeling protein function and dynamics with current AI models.
  • Potential of AI-designed proteins in applications like cancer therapy and neurodegenerative diseases.
  • The role of multiomic research in understanding causality and improving drug efficacy.
  • The implications of synthetic molecular machines for nanotechnology.
  • Integrating computational and experimental methods in protein engineering.
  • Future directions for protein design in therapeutic development, including custom protein-based solutions for disease.
  continue reading

365 episodes

Artwork
iconShare
 
Manage episode 450129047 series 1532639
Content provided by ARK Invest. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ARK Invest or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this episode of FYI, ARK Chief Investment Strategist Dr. Charles Roberts and ARK Analyst Nemo Despot, PhD speak with David Baker, Nobel Prize-winning scientist and pioneer in protein engineering. Baker shares insights into his revolutionary work on Rosetta and the evolution of AI-driven protein design tools. With advances in technologies like RoseTTAFold and generative AI, he discusses how the field is moving towards designing proteins that can neutralize pathogens, catalyze chemical reactions, and potentially combat neurodegenerative diseases. Charlie and Nemo also examine the implications for healthcare, aging, and drug discovery as Baker envisions a future where synthetic biology and AI enable groundbreaking therapeutic options.

Key Points From This Episode:

  • Introduction of David Baker and his achievements in protein design and engineering.
  • RoseTTAFold’s evolution and its role in advancing protein structure prediction.
  • How protein design could impact healthcare and the development of new therapies.
  • The use of generative AI and diffusion models in protein design for medical applications.
  • Challenges of modeling protein function and dynamics with current AI models.
  • Potential of AI-designed proteins in applications like cancer therapy and neurodegenerative diseases.
  • The role of multiomic research in understanding causality and improving drug efficacy.
  • The implications of synthetic molecular machines for nanotechnology.
  • Integrating computational and experimental methods in protein engineering.
  • Future directions for protein design in therapeutic development, including custom protein-based solutions for disease.
  continue reading

365 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play